These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2502635)

  • 1. AIDS-antiviral sulfolipids from cyanobacteria (blue-green algae).
    Gustafson KR; Cardellina JH; Fuller RW; Weislow OS; Kiser RF; Snader KM; Patterson GM; Boyd MR
    J Natl Cancer Inst; 1989 Aug; 81(16):1254-8. PubMed ID: 2502635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New soluble-formazan assay for HIV-1 cytopathic effects: application to high-flux screening of synthetic and natural products for AIDS-antiviral activity.
    Weislow OS; Kiser R; Fine DL; Bader J; Shoemaker RH; Boyd MR
    J Natl Cancer Inst; 1989 Apr; 81(8):577-86. PubMed ID: 2495366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the antiviral effect of rifabutin in AIDS-related complex.
    Torseth J; Bhatia G; Harkonen S; Child C; Skinner M; Robinson WS; Blaschke TF; Merigan TC
    J Infect Dis; 1989 Jun; 159(6):1115-8. PubMed ID: 2542419
    [No Abstract]   [Full Text] [Related]  

  • 4. Fusidic acid, HIV, and host cell toxicity.
    Richman DD; Mitsuya H; Broder S; Hostetler KY
    Lancet; 1988 May; 1(8593):1051-2. PubMed ID: 2896889
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-HIV activity of extracts and compounds from algae and cyanobacteria.
    Schaeffer DJ; Krylov VS
    Ecotoxicol Environ Saf; 2000 Mar; 45(3):208-27. PubMed ID: 10702339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of reverse transcriptase activity by extracts of cultured blue-green algae (cyanophyta).
    Lau AF; Siedlecki J; Anleitner J; Patterson GM; Caplan FR; Moore RE
    Planta Med; 1993 Apr; 59(2):148-51. PubMed ID: 7683817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A natural sulfated polysaccharide, calcium spirulan, isolated from Spirulina platensis: in vitro and ex vivo evaluation of anti-herpes simplex virus and anti-human immunodeficiency virus activities.
    Hayashi K; Hayashi T; Kojima I
    AIDS Res Hum Retroviruses; 1996 Oct; 12(15):1463-71. PubMed ID: 8893054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of serum HIV-Ag related to the major core protein (p24) in persons at risk for AIDS.
    Borghi V; De Rienzo B; Pietrosemoli P; Pecorari M; Mongiardo N; Pellegrino F; Zanchetta GP; Lami G; Squadrini F
    Microbiologica; 1989 Jan; 12(1):81-3. PubMed ID: 2497304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential target sites for antiviral inhibitors of human immunodeficiency virus (HIV).
    Oxford JS; Coates AR; Sia DY; Brown K; Asad S
    J Antimicrob Chemother; 1989 Jan; 23 Suppl A():9-27. PubMed ID: 2654120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral agents targeted to interact with viral capsid proteins and a possible application to human immunodeficiency virus.
    Rossmann MG
    Proc Natl Acad Sci U S A; 1988 Jul; 85(13):4625-7. PubMed ID: 3133655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Amino acid composition of polynucleotide-peptide complexes isolated from algae].
    Pusheva MA; Khoreva MA
    Mikrobiologiia; 1977; 46(1):62-5. PubMed ID: 404512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of tubeimoside-1 on HIV core protein p24 and cytopathogenesis in vitro.
    Yu LJ; Ma RD; Jiang SB
    Zhongguo Yao Li Xue Bao; 1994 Mar; 15(2):103-6. PubMed ID: 8010099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Broad-spectrum antiviral activity and mechanism of antiviral action of the fluoroquinolone derivative K-12.
    Witvrouw M; Daelemans D; Pannecouque C; Neyts J; Andrei G; Snoeck R; Vandamme AM; Balzarini J; Desmyter J; Baba M; De Clercq E
    Antivir Chem Chemother; 1998 Sep; 9(5):403-11. PubMed ID: 9875393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A semiautomated multiparameter approach for anti-HIV drug screening.
    Gulakowski RJ; McMahon JB; Staley PG; Moran RA; Boyd MR
    J Virol Methods; 1991 Jun; 33(1-2):87-100. PubMed ID: 1719015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation, purification, and partial characterization of prunellin, an anti-HIV component from aqueous extracts of Prunella vulgaris.
    Tabba HD; Chang RS; Smith KM
    Antiviral Res; 1989; 11(5-6):263-73. PubMed ID: 2802570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rapid and simple colorimetric test for the study of anti-HIV agents.
    Schwartz O; Henin Y; Marechal V; Montagnier L
    AIDS Res Hum Retroviruses; 1988 Dec; 4(6):441-8. PubMed ID: 2464361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro assessment of compounds for anti-HIV activity.
    Patience C; Moore J; Boyd M
    Mol Biotechnol; 1994 Feb; 1(1):49-58. PubMed ID: 7532100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antiviral effect of zidovudine and ribavirin in clinical trials and the use of p24 antigen levels as a virologic marker.
    Spector SA; Kennedy C; McCutchan JA; Bozzette SA; Straube RG; Connor JD; Richman DD
    J Infect Dis; 1989 May; 159(5):822-8. PubMed ID: 2496173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening of selected plant extracts for in vitro inhibitory activity on human immunodeficiency virus.
    Bedoya LM; Palomino SS; Abad MJ; Bermejo P; Alcami J
    Phytother Res; 2002 Sep; 16(6):550-4. PubMed ID: 12237813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Phycobiliproteins of blue-green, red and cryptophytic algae].
    Stadnichuk IN; Gusev MV
    Biokhimiia; 1979 Apr; 44(4):579-93. PubMed ID: 107977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.